ACCELERON PHARMA INC Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for September 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 17 2020 | XLRN | ACCELERON PHARMA I ... | Hamill Laura | Director | Option Exercise | A | 101.88 | 9,339 | 951,457 | 9,339 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 30.17 | 3,272 | 98,716 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 32.98 | 20,000 | 659,600 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 91.38 | 200 | 18,276 | 4,422 | 4.6 K to 4.4 K (-4.33 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 90.64 | 13,896 | 1,259,533 | 4,622 | 18.5 K to 4.6 K (-75.04 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 89.98 | 9,176 | 825,656 | 18,518 | 27.7 K to 18.5 K (-33.13 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 30.17 | 3,272 | 98,716 | 27,694 | 24.4 K to 27.7 K (+13.40 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 32.98 | 20,000 | 659,600 | 24,422 | 4.4 K to 24.4 K (+452.28 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 30.17 | 3,272 | 98,716 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 32.98 | 20,000 | 659,600 | 0 | |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 91.38 | 200 | 18,276 | 4,422 | 4.6 K to 4.4 K (-4.33 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 90.64 | 13,896 | 1,259,533 | 4,622 | 18.5 K to 4.6 K (-75.04 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 89.98 | 9,176 | 825,656 | 18,518 | 27.7 K to 18.5 K (-33.13 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 30.17 | 3,272 | 98,716 | 27,694 | 24.4 K to 27.7 K (+13.40 %) |
Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 32.98 | 20,000 | 659,600 | 24,422 | 4.4 K to 24.4 K (+452.28 %) |
Sep 09 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 89.85 | 929 | 83,471 | 19,161 | 20.1 K to 19.2 K (-4.62 %) |
Sep 09 2020 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 89.20 | 1,071 | 95,533 | 20,090 | 21.2 K to 20.1 K (-5.06 %) |